Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Get Free Report) was the target of a large drop in short interest in April. As of April 15th, there was short interest totalling 14,800 shares, a drop of 50.3% from the March 31st total of 29,800 shares. Approximately 1.7% of the shares of the stock are sold short. Based on an average daily volume of 23,800 shares, the days-to-cover ratio is currently 0.6 days.
Virpax Pharmaceuticals Price Performance
VRPX opened at $3.10 on Friday. The company’s 50 day simple moving average is $3.70 and its two-hundred day simple moving average is $4.44. Virpax Pharmaceuticals has a 1-year low of $2.40 and a 1-year high of $11.77.
About Virpax Pharmaceuticals
See Also
- Five stocks we like better than Virpax Pharmaceuticals
- What Are the FAANG Stocks and Are They Good Investments?
- 3 Stocks Leading the U.S. Agriculture Comeback
- 3 Grocery Stocks That Are Proving They Are Still Essential
- How to Use Put Debit Spreads to Profit From Falling Stocks
- How to Invest in Biotech Stocks
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Virpax Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virpax Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.